Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Endocrinology  |  Nephrology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location

Diabetic Kidney Disease Clinical Trials

A listing of Diabetic Kidney Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (51) clinical trials

This clinical trial is provided by Antidote. This research study is evaluating a new investigational medicine for patients with type 2 diabetes and severe or end-stage kidney disease. Current treatment options for such patients are limited. The study medicine is being evaluated to see if it can improve the management ...

Phase

If you’re taking High Cholesterol medication, you may qualify for a research study. Investigational medication provided at no charge Study-related care from a local doctor at no charge

Phase N/A

Local doctors need volunteers to study an investigational medication.

Phase N/A

The primary objective of this study is to: Demonstrate whether, in addition to standard of care (SoC), finerenone is superior to placebo in delaying the progression of kidney disease, as measured by the composite endpoint of time to first occurrence of kidney failure, a sustained decrease of eGFR ≥ 40% ...

Phase

The primary objective of this study is to: Demonstrate whether, in addition to standard of care (SoC), finerenone is superior to placebo in delaying the time to first occurrence of cardiovascular (CV) mortality and morbidity in subjects with type 2 diabetes mellitus and the clinical diagnosis of diabetic kidney disease ...

Phase

The purpose of the study is to evaluate whether or not atrasentan is effective in delaying the worsening of kidney disease by comparing the time to serum creatinine doubling or the onset of end stage renal disease in patients with Type 2 diabetes and kidney disease.

Phase

The purpose of the study is to find out if canagliflozin has a kidney and cardiovascular protective effect to reduce the progression of diabetic kidney and heart disease compared to placebo.

Phase

Demonstrate whether finerenone QD is superior to placebo QD in delaying the time to first occurrence of cardiovascular mortality and morbidity in subjects with T2DM and the clinical diagnosis of DKD. Randomized at 1:1 ratio. Subjects will take one pill once a day.

Phase

A research study is evaluating an investigational medication for kidney disease.

Phase N/A